CureVac Company Profile, Contacts & Intelligence

CureVac Overview

CureVac (Nasdaq: CVAC) is a pioneering multinational biotech company founded in 2000 to advance the field of messenger RNA (mRNA) technology for application in human medicine. In more than two decades of developing, optimizing, and manufacturing this versatile biological molecule for medical purposes, CureVac has introduced and refined key underlying technologies that were essential to the production of mRNA vaccines against COVID-19, and is currently laying the groundwork for application of mRNA in new therapeutic areas of major unmet need. CureVac is leveraging mRNA technology, combined with advanced omics and computational tools, to design and develop off-the-shelf and personalized cancer vaccine product candidates. It also develops programs in prophylactic vaccines and in treatments that enable the human body to produce its own therapeutic proteins. Headquartered in Tübingen, Germany, CureVac also operates sites in the Netherlands, Belgium, Switzerland, and the U.S. Further information can be found at www.curevac.com.

Headquarters

Tuebingen, Baden-württemberg, De

Website

curevac.com

Industry

Biotechnology Research

Founded

2000

Stock Symbol

CVAC

NAICS

Research and Development in Biotechnology (except Nanobiotechnology)

Phone Number

Available in AeroLeads

Company Email

Available in AeroLeads

CureVac Contact Intelligence

See which contact channels and departments are represented in the visible AeroLeads data.

CureVac People & Org Chart Preview

Sample people records show job titles and whether email or phone data is available without exposing raw contact details.

CureVac Workforce Composition

Seniority breakdown across 54 visible profiles.

CureVac Technology & Talent

Technology-related job titles represented in the visible people data.

Compare Similar Companies to CureVac

Explore companies in related markets and compare their industry and employee estimates.